Mechanisms of L-DOPA-induced dyskinesia in Parkinson's disease [electronic resource] / Angela Cenci.
Material type:
FilmSeries: Henry Stewart talksBiomedical & life sciences collection. Parkinson's disease: Publisher: London : Henry Stewart Talks, 2014Description: 1 online resource (1 streaming video file (44 min.) : color, sound)Other title: Mechanisms of L-3,4-dihydroxyphenylalanine (L-DOPA)-induced dyskinesia in Parkinson's diseaseSubject(s): Antiparkinsonian agents -- Side effects | Dopa -- Physiological effect | Parkinson's disease -- Chemotherapy | Parkinson's disease -- Treatment | Antiparkinson Agents -- therapeutic use | Antiparkinson Agents -- toxicity | Dyskinesia, Drug-Induced -- physiopathology | Dyskinesia, Drug-Induced -- therapy | Levodopa -- toxicity | Parkinson Disease -- drug therapy | Parkinson Disease -- physiopathology | Parkinson Disease -- therapyOnline resources: Click here to access online | Series Animated audio-visual presentation with synchronized narration.
Title from title frames.
Contents: Characteristics of Parkinson´s disease (PD) -- Dysregulation of dopamine release and re-uptake in the striatum -- L-DOPA as a drug for PD -- L-DOPA-induced dyskinesia (LID) -- Pre- and post-synaptic mechanisms of LID -- Serotonin neurons, dopamine and LID -- Genes linked to involuntary movements (ΔFosB, ERK1/2, mGluR5) -- Spiny projection neurons (SPNs) in PD and LID.
Access restricted to subscribers.
Mode of access: World Wide Web.